A Phase 1 Open Label Trial of Intravenous Administration of MVA-BN-Brachyury Vaccine in Patients With Advanced Cancer

Clinical trial NCT04134312 · COMPLETED

Trial details

NCT number: NCT04134312
Sponsor: Bavarian Nordic
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Metastatic Tumor

Start date: 2020-01-08
Primary completion: 2021-01-12
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.